September 14, 2017: In the Know

 // News

September 14  

  1. Three Prime Opportunities in the Digital Health Market
  2. Teva Appoints New Chief Executive After Months of Speculation
  3. Fresh Paint, New HQ for StemoniX 
  4. Minneapolis Heart Institute Foundation Enrolls First Patient in TRILUMINATE Tricuspid Repair Trial
  5. These pigs are helping researchers find cures for cancer, and could someday grow human organs
  6. St. Teresa Medical Announces First Commercial Use of SURGICLOT® in Auckland, New Zealand
  7. DiaMedica Announces the Initiation of Phase 2 Trial Evaluating DM199 (Recombinant Human KLK1) in Patients with Acute Ischemic Stroke
  8. Vanguard Medical Group Partners with Zipnosis to Improve Patient Access by Launching Virtual Care
  9. Baird Capital Promotes Three
  10. Rebiotix Seeks $10M in Funding Round
  11. Bio-Techne Acquires Trevigen Inc.
  12. MedNet Solutions Announces Technology Partnership With arivis
  13. Spotlight Innovation, Indiana University to Jointly Research, Develop New SMA Therapies
  14. Mayo Clinic Care Network Expands into China
  15. Heraeus Medical Components LLC has acquired Biotectix LLC assets
  16. Teva to sell contraceptive brand Paragard in $1.1 billion deal
  17. VivaQuant and DSI Announce Agreement
  18. AtriCure Announces U.S. Launch of the AtriClip® PRO•V™ Device
  19. How the University of Minnesota Turns its Research into Startups
  20. Humanetics Awarded Patent for Drug That Improves the Effectiveness of Radiation Treatment for Cancer
  21. SPR Therapeutics® Secures $25 Million in Series C Financing
  22. Human Emotions on a Healthcare Platform for Cancer Survivors
  23. Cogentix Medical Announces Cahaba GBA, LLC Extends Coverage for Urgent PC Maintenance Therapy
Success message!
Warning message!
Error message!